An e-liquid, comprising naringenin, wherein the content of naringenin in the e-liquid is 0.09% to 10% the total weight of the e-liquid. After the e-liquid is atomized, the naringenin contained therein may be atomized together with the e-liquid and absorbed by a human body, thereby achieving anti-inflammatory, cough-relieving and phlegm-eliminating effects, and inhibiting oral and respiratory bacteria. Moreover, the taste of the e-liquid after atomization is made more comfortable and milder, the aroma of the cigarette is enriched, and the quality of smoking is improved.
展开▼